NCT00456092 Phase II Study of Apremilast (CC-10004) in Adults With in Psoriatic Arthritis Status COMPLETED Phase PHASE2
NCT00454857 Retrospective & Prospective Observational Study of Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Status COMPLETED Phase N/A
NCT00454779 PARTNER: Panitumumab Added to Regimen for Treatment of Head aNd Neck Cancer Evaluation of Response Status COMPLETED Phase PHASE2
NCT00450658 Efficacy and Safety Study of HZT-501 in Reducing the Risk of Ibuprofen-associated Ulcers Status COMPLETED Phase PHASE3
NCT00450216 Efficacy and Safety Study of HZT-501 in Subjects Requiring Nonsteroidal Anti-Inflammatory Drug (NSAID) Treatment Status COMPLETED Phase PHASE3
NCT00448786 Effect of Different Doses of AMG 706 on the Gallbladder in Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00446446 PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer) Status COMPLETED Phase PHASE2
NCT00445042 Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer Status COMPLETED Phase PHASE2
NCT00443430 Trial of Early Aggressive Drug Therapy in Juvenile Idiopathic Arthritis Status COMPLETED Phase PHASE4
NCT00443326 AMG 714 20060349 Multiple Dose Study in Moderate to Severe Psoriasis Subjects Status COMPLETED Phase PHASE2
NCT00436995 Extension From Weekly to Once Every Other Week Darbepoetin Alfa Administration in Subjects With Chronic Kidney Disease Receiving Dialysis Status COMPLETED Phase PHASE3
NCT00436748 Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Patients With Chronic Kidney Disease Status TERMINATED Phase PHASE3
NCT00431496 A Study of Cinacalcet to Improve Achievement of National Kidney Foundation Kidney Disease Outcomes Quality Initiative (K/DOQI) Targets in Patients With End Stage Renal Disease (ESRD) Status COMPLETED Phase PHASE4
NCT00425204 Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment Status COMPLETED Phase PHASE2
NCT00425035 Safety and Efficacy Study of ABX-EGF in Patients With Renal Cancer, Part 2 Status COMPLETED Phase PHASE2